Rybelsus 14 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQ0Y0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,522
Award facts
- Contract value 100% obligated
- $19,522.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,522.34 to AmerisourceBergen Drug Corp for the supply of Rybelsus 14 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on August 29, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for delivery to be completed by September 2, 2025, with performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. Rybelsus is an oral diabetes medication used in the management of type 2 diabetes, supporting military healthcare and veteran medical supply requirements.
This delivery order is part of AmerisourceBergen's broader engagement with the Defense Logistics Agency, which includes a prime indefinite delivery vehicle valued at $999,999,999.00 through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen maintains a substantial portfolio of federal contracts with DLA covering a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's role as a critical vendor in the Defense Health Agency supply chain underscores its significance in ensuring consistent access to essential medications for military personnel and the broader federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FQ0Y0?
SPE2DB25FQ0Y0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FQ0Y0 worth?
The government has obligated $19,522 on SPE2DB25FQ0Y0.
Is contract SPE2DB25FQ0Y0 an order under another contract?
Yes. SPE2DB25FQ0Y0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0Y0 competed?
The extent of competition for SPE2DB25FQ0Y0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award